FDA Approves First Oral Blood Thinning Medication for Children
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a …
FDA Approves First Oral Blood Thinning Medication for Children Read More